Time and Place

The Clifton Mining Company shareholder meeting was held at the Alpine Arts Center on August 2nd at 12:30 pm.

Quorum And Shareholder Business

The accounting company determined that a quorum was present and that voting had been completed. Both board members up for re-election were elected.

Presentation Of Current Company Position By Keith Moeller

Clifton Is A Richly Diverse And Unique Company

• Clifton currently has a property joint venture with Dumont Nickel Inc. The joint venture currently holds 108 mining lode claims and 28 patented claims. (These are claims that have been proven to have mineral value)

• Clifton owns 61% of Woodman Mining Company

• Clifton owns water rights in desert lands

• Clifton owns 23% of American Biotech Labs

• Clifton has no significant debt

Mining Claims

Clifton’s claims (approximately five square miles) are located in a historic mining district that has produced gold, silver, lead, copper and other metals.

By law, a mining claim could be patented only if it was proven that a mineable deposit exists on the claim. Clifton’s patented claims are listed as having known deposits of gold, silver, copper, and lead.

Woodman Mining Company

Clifton owns 61% of Woodman Mining Company, the owner of the Cane Springs gold property. Dumont has also earned an interest in the Cane Springs property by spending funds that led to the discovery of a second gold-bearing structure similar to the historic mine on the property. The mine was a high-grade gold producer, and drilling by Dumont has found gold values in the newly found structure up to 6 ounces of gold per ton. Average values have yet to be determined, but indications suggest a profitable deposit. The new system comes to the surface 2,000 feet south of Clifton’s mill.

Water Rights

Clifton currently owns water rights near the town sites of Gold Hill and Clifton, and has the capacity to supply all of its needs. Large flows from these sources would allow Clifton to sell excess water. The water is rich with naturally occurring minerals and may hold value as a source of concentrated natural trace minerals.

Dumont Joint Venture-Completed List

• The joint venture has expanded the property to eight times its original size.

• The venture has completed surface sampling on much of the expanded property.

• The venture acquired and drilled a known deposit outside of Clifton’s property area (Kiewit Gold Zone).

• Dumont has spent millions of dollars doing exploration, furthering the interests and value of Clifton and its shareholders, at little cost to Clifton.

Known Mineralization

There are hundreds of mineral occurrences on the property, where minerals come to the surface. There are three areas on the property are of particular interest.

Kiewit Gold Zone

We believe the Kiewit Gold Zone holds between 75,000-200,000 ounces of mineable gold. The deposit is currently being reviewed to certify reserves.

Cane Springs

The Cane Springs is a past producing, high-grade gold mine with gold values well over an ounce per ton. Some of the existing mine pillars were assayed at as much as nine ounces of gold per ton. Dumont discovered a second gold bearing structure a few hundred yards from the original mine working. The newly discovered structure was then drilled and it was confirmed that the deposit continues to depth. The new deposit could hold as much as 100,000-200,000 contained ounces of gold. Phase one drilling has been completed. Management is now deciding if it is better to go on to phase two drilling or to use the same money to open and start mining the property.

Shear Zones

The Shear Zones are a series of lead /silver/gold veins on the south side of the property. A 2000 report, completed before SEC definitions of “proven and probable ore” changed, states that the Shear veins hold 581,300 tons of proven and probable resource, containing 4.8 million ounces of silver, 26,626 ounces of gold, and 30,227 tons of lead (5.2%). The deposits are open at depth and along strike.

Near Term OBJECTIVES

1) Obtain a certified report for the Kiewit Gold Property.

2) Negotiate release of claims not currently of interest to our partner, and possibly bring in a new partner.

American Biotech Labs

Brief History

American Biotech Labs is a private company started by the Moeller family and associates. The Moeller’s arranged that Clifton could buy a position in the company, affording Clifton the opportunity for an alternative source of income. The total cost to Clifton was $20,000. Clifton currently owns about 22-23% of ABL. The stock that Clifton has purchased over time in the company has grown in value from $20,000 to an estimated $8,000,000 at today‘s prices for ABL stock ($5/share). ABL continues to grow and prosper.

ABL Accomplishments Since Last Shareholder Meeting

• New patents were issued (Oct 2006) including the use of ABL’s silver to kill bacteria and to treat illness. The average sizes of the silver nano-particles were patented. Use of the silver against viruses including HIV was patented.

• New EPA approvals (Nov 2006) were obtained for use of the ABL silver as a surface disinfectant against black mold, yeast and a couple other bacteria. The approvals also include use as a disinfectant for heating and ventilation systems.

• The EPA approved the ASAP-AGX-32® product as a dental water line disinfectant. The product was approved to kill the bacteria in the dental water lines at 22 ppm and to keep it from growing at 0.50 ppm. The company has signed a contract with Henry Schein to distribute the product to dentists nationwide.

• A peer review paper “Bacterial Activity Of Combinations Of Silver-Water Dispersion With 19 Antibiotics Against Seven Microbial Strains” was published on the use of the ABL silver products including the use against multi-drug resistant strains” (Oct 2006). The paper shows that the silver kills first-order mutant pathogens (a critical issue in medicine, as these mutations may be resistant to antibiotics). In addition, the silver generally enhances or is neutral to the ability of antibiotics to kill pathogens. Copies of the paper can be found on the ABL Website under the heading of Peer Review Papers. The company has filed a trade mark of the name “Silver Water Dispersion”.

• A peer-review paper, ‘Ultradilute Ag-aquasols with extraordinary bactericidal properties: role of the system Ag-O-H2O” was published in 2007. This reflected work done at the top ranked material science lab in the world at Penn State University under the direction of world renowned scientist Rustum Roy. The report was co-authored by seven other distinguished professors from a number of universities. The paper, written about the ABL silver, states that these aquasols “are extraordinary, powerful, bactericidal inorganic agents equal to most commercial antibiotics”. The paper can be found on the ABL Website under the heading of Peer Review Papers.

*American Biotech Labs was the recipient of the “Best Of State” award for the state of Utah for Medical Innovation. The award was granted to ABL for its work on diseases ranging from Malaria to Avian Influenza (THE BIRD FLU). Management feels honored to receive such an award especially since only one award was given for medical innovation and there are hundreds of biotech and pharma companies as well as universities that could have received the honor.

• ABL leased a new building and constructed a new production facility therein. The facility has the capacity of producing 1.5 million bottles of product a month. ABL also purchased its own bottling/labeling machine with the capacity to bottle/label 60 bottles a minute.

• ABL has purchased and installed new gel manufacturing and tubing machinery. The new bottling and tubing machines are online and have government approval to produce product.

New Key Employees and Consultants

• Dr. Gordon Pedersen has joined the staff of ABL. Dr. Pedersen is a New York Times best- selling author, and professional speaker. He has degrees in both Toxicology and Cardiovascular Rehabilitation. Dr. Pedersen has formulated over 150 products. He brings the company vast experience in both national and international sales and product promotion. He has experience working in NIH virology labs.

• Col. Robert Saum (ret) has joined the staff of ABL. Dr. Saum is the current president of the United States Special Operations Medical Association. He recently retired as the senior interagency coordinator for Homeland Security. Dr. Saum has a wealth of experience working with military and government agencies, both domestic as well as internationally.

• Col. Allan Moloff MD (ret) has become an adviser to the company. Dr. Moloff was commander of the US Special Forces Operations Medical Command, Commander Aeromedical Center & Defense Medical Readiness Training Institute, Board of Aerospace Medicine, American Board of Disaster Medicine, Associate Professor of Department of Internal Medicine etc.

FDA Gel Products

On the morning of our shareholder meeting (August 2), our FDA legal team, along with Dr. Pedersen and Dr. Moloff, met with the FDA representatives to move our gel products toward final approval. We are presently making the needed changes.

Continued Studies

American Biotech Labs is involved in a number of studies. Two of these are finished and in peer review. They will be released in peer review journals, at witch point we will announce them